SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is facing intense downward pressure and widespread community skepticism as investors debate the sustainability of its debt-fueled Bitcoin accumulation strategy and the potential for systemic risk. The stock is a focal point for intense conflict between those calling for a structural collapse and those viewing the current volatility as a generational buying opportunity.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing significant momentum and heightened social media activity driven by reports of a manufacturing partnership with Apple for domestic chip production. The community remains deeply divided, with some investors focusing on the stock's long-term potential as a cornerstone of U.S. semiconductor infrastructure, while others express skepticism over the sustainability of the price action and the reliability of the news flow.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is seeing intense trading volume and volatility as retail investors and algorithms debate whether the memory stock is in a sustainable growth phase or a speculative bubble driven by AI infrastructure demand. The community is heavily split, with bulls pointing to supply shortages and institutional momentum, while bears argue the valuation has decoupled from fundamentals and caution that the stock is poised for a significant correction.

Arqit Quantum, Inc. engages in the provision of cybersecurity services via satellite and terrestrial forms. Its product is QuantumCloud which secures devices with cloud-based quantum encryption. The company was founded by David John Williams and David James Bestwick on April 26, 2021 and is headquartered in London, the United Kingdom.

Arqit Quantum Inc

Arqit Quantum is experiencing high volatility as investors track significant insider accumulation and a tightening share float, with the community actively speculating on potential government contract catalysts and a possible short squeeze. Sentiment is largely divided between bullish investors eyeing the stock's role in the quantum security sector and skeptics concerned about the company's limited revenue and ongoing legal overhangs.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is seeing a strong rally driven by institutional interest and optimism surrounding the upcoming FDA review of compounded weight-loss peptides. While the community is actively debating the stock's path toward previous highs and the potential for a short squeeze, many are focused on the company's expanding telehealth platform and its ability to capture market share in the growing GLP-1 and wellness space.

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is rallying as investors react to strong quarterly growth, a transformative shift toward a semiconductor-based business model, and a high-profile partnership with Midjourney. While the community is debating potential future share offerings and the long-term competitive landscape, bullish sentiment remains centered on the company's proprietary chip technology and aggressive expansion into point-of-care AI imaging.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna shares are trending as investors weigh an upcoming FDA advisory committee meeting for its mRNA flu vaccine against the company's broader efforts to expand its pipeline in oncology and rare diseases. The community remains sharply divided, with bulls pointing to long-term pipeline potential and clinical progress, while bears continue to scrutinize the company's path to profitability and recent regulatory hurdles.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors react to the company's recent repurchase of $16 million in convertible notes and the upcoming EMA decision on Yartemlea. While the community is actively debating the strategic implications of debt reduction and potential buyout interest, sentiment remains split between long-term optimism over pipeline catalysts and frustration regarding management's communication style.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is surging as investors pivot to its new AI infrastructure identity, fueled by the formal completion of its Northern Data acquisition and the launch of the 'Quake AI' division. The community is buzzing over the massive influx of GPU capacity and potential cloud contracts, creating high conviction among bulls regarding a massive short squeeze and long-term valuation re-rate.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF is experiencing intense volatility and heavy sentiment polarization, with traders debating whether the sector is in a sustainable super-cycle fueled by massive AI data center demand or a classic speculative bubble nearing a blowoff top. Investors are actively watching for potential catalysts like FOMC decisions and sector-specific earnings, while balancing concerns over leverage, regulatory noise, and the broader macro environment against aggressive dip-buying patterns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Kailera Therapeutics a Buy After Its Sizzling IPO?

Is Kailera Therapeutics a Buy After Its Sizzling IPO...

A Kailera Therapeutics (KLRA) Insider Scooped up an Additional 500,000 Shares for $8.0 Million

Key Points500,000 shares were acquired for a transaction value of $8.00 million on April 20, 2026...

Hengrui Pharma Reports Q1 2026 Results with Revenue and Net Profit Growth

Hengrui Pharma Reports Q1 2026 Results with Revenue and Net Profit Growth Hengrui Pharma Reports Q1 2026 Results with Revenue and Net Profit Growth PR Newswire SHANGHAI, April 22, 2026 SHANGHAI...

Kailera Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity. Its product candidate includes Ribupatide. The company was founded on May 08, 2024 and is headquartered in Waltham, MA.

Kailera Therapeutics Inc.

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$19.45
Prev Close	$19.13
Open	$20.03
Dividend Yield	N/A
50-Day Moving Average	$21.96
Beta	0.00
Avg. Volume	439,191.49
PE Ratio	N/A

52-Week High	$28.23
52-Week Low	$16.00
Market Capitalization	$2.48B
EPS (Annual)	-$1.76
Price to Book	-5.74
Revenue Per Employee	$0.00

KLRAKailera Therapeutics Inc.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KLRA News